Resource Planning Group Takes $210,000 Position in SPDR S&P Biotech ETF (XBI)

Share on StockTwits

Resource Planning Group purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 2,186 shares of the exchange traded fund’s stock, valued at approximately $210,000.

Other hedge funds have also modified their holdings of the company. Rockefeller Capital Management L.P. purchased a new position in shares of SPDR S&P Biotech ETF in the second quarter valued at approximately $130,000. WP Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF in the second quarter valued at approximately $133,000. Trust Co. of Vermont purchased a new position in shares of SPDR S&P Biotech ETF in the second quarter valued at approximately $136,000. Squar Milner Financial Services LLC purchased a new position in shares of SPDR S&P Biotech ETF in the second quarter valued at approximately $139,000. Finally, Moneta Group Investment Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF in the second quarter valued at approximately $144,000.

Shares of NYSEARCA XBI traded up $0.77 during midday trading on Wednesday, hitting $84.01. The stock had a trading volume of 173,847 shares, compared to its average volume of 4,760,007. SPDR S&P Biotech ETF has a 1 year low of $76.37 and a 1 year high of $101.55.

WARNING: “Resource Planning Group Takes $210,000 Position in SPDR S&P Biotech ETF (XBI)” was originally posted by Week Herald and is owned by of Week Herald. If you are viewing this article on another domain, it was illegally stolen and republished in violation of international copyright & trademark legislation. The original version of this article can be accessed at https://weekherald.com/2018/11/07/resource-planning-group-takes-210000-position-in-spdr-sp-biotech-etf-xbi.html.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Story: Swap

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply